Moderna Wins COVID Patent Dispute with Pfizer, BioNTech

May 17, 2024, 04:30 PM

Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine. The European Patent Office decided to uphold the validity of one of two disputed patents, providing a significant boost for Moderna. The decision, announced on Friday, marks a victory for Moderna in the ongoing legal battle over the intellectual property rights related to its COVID-19 shot.